Skip to main content
Log in

Pharmacokinetics of quinidine and three of its metabolites in man

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Disposition parameters of quinidine and three of its metabolites, 3-hydroxy quinidine, quinidine N-oxide, and quinidine 10,11-dihydrodiol, were determined in five normal healthy volunteers after prolonged intravenous infusion and multiple oral doses. The plasma concentrations of individual metabolites after 7 hr of constant quinidine infusion at a plasma quinidine level of 2.9±(SD) 0.3 mg/L were: 3-hydroxy quinidine, 0.32±0.06 mg/L; quinidine N-oxide, 0.28±0.03 mg/L; and quinidine 10,11-dihydrodiol, 0.13±0.04 mg/L. Plasma trough levels after 12 oral doses of quinidine sulfate every 4 hr averaged: quinidine, 2.89±0.50 mg/L; 3-hydroxy quinidine, 0.83±0.36 mg/L; quinidine N-oxide, 0.40±0.13 mg/L; and quinidine 10,11-dihydrodiol, 0.38±0.08 mg/L. Relatively higher plasma concentrations of 3-hydroxy quinidine metabolite after oral dosing probably reflect first-pass formation of this quinidine metabolite. A two-compartment model for quinidine and a one-compartment model for each of the metabolites described the plasma concentration-time curves after both i.v. infusion and multiple oral doses. Mean (±SD) disposition parameters for quinidine from individual fits, after i.v. infusion were as follows: V 1 ,0.37±0.09 L/kg; λ1,0.094±0.009 min −1; λ2, 0.0015±0.0002 min−1; EX2, 0.013±0.002 min−1;clearance (ClQ),3.86±0.83 ml/min/kg. Both plasma and urinary data were used to determine metabolic disposition parameters. Mean (±SD) values for the metabolites after i.v. quinidine infusion were as follows: 3-hydroxy quinidine: formation rate constant kmf,0.0012±0.0005 min −1,volume of distribution, Vm,0.99±0.47 L/kg; and elimination rate constant, kmu 0.0030±0.0002 min −1.Quinidine N-oxide: kmf,0.00012±0.00003 min −1; Vm,0.068±0.020 L/kg; and kmu,0.0063±0.0008 min −1.Quinidine 10,11-dihydrodiol: kmf,0.0003±0.0001 min −1; Vm,0.43±0.29 L/kg; and kmu,0.0059±0.0010 min −1.Oral absorption of quinidine was described by a zero order process with a bioavailability of 0.78. Concentration dependent renal elimination of 3-hydroxy quinidine was observed in two out of five subjects studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. C. T. Ueda, B. J. Williamson, and B. S. Dzinzio. Absolute quinidine bioavailability.Clin. Pharmacol. Ther. 20:260–265 (1976).

    CAS  PubMed  Google Scholar 

  2. T. W. Guentert, N. H. G. Holford, P. E. Coates, R. A. Upton, and S. Riegelman. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.J. Pharmacokin. Biopharm. 7:315–330 (1979).

    Article  CAS  Google Scholar 

  3. D. J. Greenblatt, H. J. Pfeifer, H. R. Ochs, D. S. Maclaughlin, T. W. Smith, and J. Koch-Weser. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.J. Pharmacol. Exp. Ther. 202:365–378 (1977).

    CAS  PubMed  Google Scholar 

  4. D. E. Drayer, M. Hughes, B. Lorenzo, and M. M. Reidenberg. Prevalance of high (3S)-3-hydroxy quinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.Clin. Pharmacol. Ther. 27:72–75 (1980).

    Article  CAS  PubMed  Google Scholar 

  5. N. H. G. Holford, P. E. Coates, T. W. Guentert, S. Riegelman, and L. B. Sheiner. The effect of quinidine and its metabolites on the electrocardiogram and systolic intervals.Br. J. Clin. Pharmacol. 11:187–195 (1981).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. D. E. Drayer, D. T. Lowenthal, K. M. Restivo, A. Schwartz, C. E. Cook, and M. M. Reidenberg. Steady-state serum levels of quinidine and active quinidine metabolites in cardiac patients with varying degrees of renal function.Clin. Pharmacol. Ther. 24: 31–39 (1978).

    CAS  PubMed  Google Scholar 

  7. A. Rakhit, M. Kunitani, N. H. G. Holford, and S. Riegelman. Improved liquid-chromatographic assay of quinidine and its metabolites in biological fluids.Clin. Chem. 28:1505–1509 (1982).

    CAS  PubMed  Google Scholar 

  8. T. W. Guentert, J. J. Daly, and S. Riegelman. Isolation and identification of a new quinidine metabolite.Eur. J. Drug Metab. Pharmacokin. 7:31–38 (1982).

    Article  CAS  Google Scholar 

  9. Y. Yanuka, S. Yosselson-Superstine, G. Geryes, and E. Superstein. Assignment and configuration to potassium permanganate oxidation products of quinidine.J. Pharm. Sci. 70:675–679 (1981).

    Article  CAS  PubMed  Google Scholar 

  10. L. Z. Benet. General treatment of linear mamillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536–541 (1972).

    Article  CAS  PubMed  Google Scholar 

  11. M. Gibaldi and D. Perrier.Pharmacokinetics, Mercel Dekker, New York, 1975, p. 101.

    Google Scholar 

  12. N. H. G. Holford,MKMODEL. In H. M. Perry and J. J. Wood (editors),Public Procedures Notebook. Bolt Beranek and Newman, Cambridge, Mass., 1981, pp. 8–51.

    Google Scholar 

  13. W. F. Raub, “PROPHET” system and resource sharing.Fed. Proc. 33:2390 (1976).

    Google Scholar 

  14. E. P. Hiatt. Plasma concentrations following the oral administration of a single dose of the principal alkaloids of cinchona bark,J. Pharmacol. Exp. Ther. 81:160–163 (1944).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by funds from the grants GM 26691 and GM 28072 from the National Institute of General Medical Sciences, NIH. A. Rakhit was the recipient of a Training Grant Traineeship from NIH. T. W. Guentert is grateful for support from the Swiss National Science Foundation.

Professor Sidney Riegelman. deceased April 4, 1981.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rakhit, A., Holford, N.H.G., Guentert, T.W. et al. Pharmacokinetics of quinidine and three of its metabolites in man. Journal of Pharmacokinetics and Biopharmaceutics 12, 1–21 (1984). https://doi.org/10.1007/BF01063608

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01063608

Key words

Navigation